Daily Market Wrap-Up by Stock Whisperers: [24-JULY-2024]

Market Wrap-Up Your daily dose of market insights and stock updates

24-JULY-2024

Market Overview:

Summary of the Day's Market Performance

  • Nifty declined by -0.3% and Sensex by -0.4%.

  • Midcaps rose by +1% and Smallcaps rebounded with a +1.8% gain.

"Nifty (-0.3%) and Sensex (-0.4%) ended in the red. Midcaps (+1%) and Smallcaps (+1.8%) bounced back after yesterday’s fall."

Sector Highlights:

Performance of Key Sectors

  • Top Performers: Oil & Gas (+1.7%), Real Estate (+0.8%), Pharma (+0.7%).

  • Underperformers: Banks (-0.9%), NBFCs (-0.6%), FMCG (-0.5%).

"Most sectors ended in the green. Oil & Gas (+1.7%), Real Estate (+0.8%), and Pharma (+0.7%) saw the most buying. Banks (-0.9%), NBFCs (-0.6%), and FMCG (-0.5%) witnessed some selling pressure."

Market Transactions:

• 📉FII Sold: -5,130.90 cr.

• 📈DII Bought: 3,137.30 cr.

Stock News:

Key Stock Movements and News

  • Top Nifty Losers: Bajaj Finserv, Britannia Industries, Bajaj Finance, Tata Consumer, Axis Bank.

  • Top Nifty Gainers: HDFC Life, Tech Mahindra, BPCL, NTPC, Tata Motors.

  • Bajaj Finance: Fell -2% after its Q1 raised some red signals.

  • United Spirits: (+5%) hit a lifetime high.

  • Ola Electric: Plans a $740 mn IPO likely in August, targeting a $4-4.25 billion valuation.

  • Jefferies on ICICI Prudential: Maintains 'buy' rating with a target of Rs 750.

  • CG Power: To acquire 55% stake in GG TRonics for Rs 319.4 crore.

  • Syngene International: Q1 net profit down to Rs 76 crore from Rs 93 crore, YoY.

  • SpiceJet: Board approves Rs 3000 crore fundraising.

  • Sterlite Technologies: Extends partnership with Netomnia to develop a full-fibre network in the UK.

  • Butterfly Gandhimathi: Q1 net profit down 83% at Rs 2.5 crore Vs Rs 14.7 crore, YoY.

  • Bajel Projects: Shares rise 7% on winning a contract of Rs 686 crore.

  • Alembic Pharma: Gets USFDA nod for Luphenazine Hydrochloride Tablets.

Support and Resistance :

NIFTY

BANKNIFTY

Stocks to Focus On:

Bliss GVS Pharma Limited

  • Current Market Price (CMP): ₹121.20

  • The company's solid financial performance, continuous innovation, regulatory approvals, and expansion plans, a short-term investment could be considered.

  • Target Expectation: Based on current financials and market conditions, a reasonable short-term target could be in the range of ₹135-145, assuming market stability and no major negative developments.

Conclusion:

Summary and Outlook

"In summary, the Indian markets saw a mixed performance with Nifty and Sensex ending slightly in the red. Midcaps and Smallcaps showed strong recovery. Oil & Gas, Real Estate, and Pharma sectors led the gains, while Banks, NBFCs, and FMCG sectors faced selling pressure. Investors will be closely watching upcoming earnings reports and market trends for further direction."

😊Thank you for subscribing to our Market Wrap-Up. Stay tuned for tomorrow's update.

Disclaimer: The information provided in this newsletter is for informational purposes only and should not be considered financial advice.

Follow us on Social Media 👇